As a Group Leader and Principal Scientist at KBI Biopharma, Valery Tangham leverages over 15 years of extensive experience in Quality Control and Analytical Method Development and Validation to drive excellence in biopharmaceutical programs. In this pivotal role, Valery oversees a diverse portfolio of Drug...
As a Group Leader and Principal Scientist at KBI Biopharma, Valery Tangham leverages over 15 years of extensive experience in Quality Control and Analytical Method Development and Validation to drive excellence in biopharmaceutical programs. In this pivotal role, Valery oversees a diverse portfolio of Drug Substance and Drug Product projects, ensuring compliance with stringent FDA GMP regulations and industry standards. His expertise spans a wide range of analytical techniques, including protein assays and stability testing, which are essential for the successful release and lifecycle management of both clinical and commercial products.
Valery is particularly passionate about fostering a culture of quality and reliability within his team. He leads key initiatives focused on analytical method transfer, qualification, and validation, ensuring that all processes align with the highest quality systems and regulatory requirements. His adeptness in change control and data analysis enables him to navigate complex challenges and implement innovative solutions that enhance operational efficiency.
Currently, Valery is spearheading several high-impact projects that aim to streamline analytical workflows and improve the robustness of quality control measures across various biopharmaceutical programs. His commitment to continuous improvement and his deep understanding of Chemistry, Manufacturing, and Controls (CMC) make him a vital asset to KBI Biopharma. By mentoring emerging scientists and collaborating with cross-functional teams, Valery not only contributes to the success of current projects but also shapes the future of biopharmaceutical development, ensuring that the highest standards of quality are met at every stage of the product lifecycle.
